Kamoun, W. S., Ley, C. D., Farrar, C. T., Duyverman, A. M., Lahdenranta, J., Lacorre, D. A., . . . Jain, R. K. (2009). Edema Control by Cediranib, a Vascular Endothelial Growth Factor Receptor–Targeted Kinase Inhibitor, Prolongs Survival Despite Persistent Brain Tumor Growth in Mice. American Society of Clinical Oncology.
Citação norma ChicagoKamoun, Walid S., et al. Edema Control By Cediranib, a Vascular Endothelial Growth Factor Receptor–Targeted Kinase Inhibitor, Prolongs Survival Despite Persistent Brain Tumor Growth in Mice. American Society of Clinical Oncology, 2009.
Citação norma MLAKamoun, Walid S., et al. Edema Control By Cediranib, a Vascular Endothelial Growth Factor Receptor–Targeted Kinase Inhibitor, Prolongs Survival Despite Persistent Brain Tumor Growth in Mice. American Society of Clinical Oncology, 2009.